Principal Scientist
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Aryun Kim, PharmD, is currently Principal Scientist in Clinical Pharmacology at Gilead Sciences. She obtained her PharmD at Rutgers University and completed her Infectious Diseases Pharmacotherapy Fellowship at Hartford Hospital under Dr David Nicolau. She has 15 years of experience, primarily in anti-infectives, including regulatory (FDA) and industry (AstraZeneca, Achaogen, BioMarin).